Respiratorius AB (XSAT:RESP) Cyclically Adjusted PB Ratio: (As of Aug. 24, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSAT:RESP Respiratorius AB XSAT:RESP
33 GF Score
Price kr2.33
View Full Analysis

What is Respiratorius AB Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Respiratorius AB  (XSAT:RESP) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Respiratorius AB Cyclically Adjusted PB Ratio Related Terms


Respiratorius AB Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Respiratorius AB's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Respiratorius AB Cyclically Adjusted PB Ratio Chart

Respiratorius AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 3.25 1.71 0.45 0.12

Respiratorius AB Quarterly Data
Jun21 Sep21 Dec21 Apr22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.56 0.19 0.12 0.10 0.00

XSAT:RESP vs VRTX, REGN, RVMD: Cyclically Adjusted PB Ratio Comparison

For the Biotechnology subindustry, Respiratorius AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Respiratorius AB Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Respiratorius AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Respiratorius AB's Cyclically Adjusted PB Ratio falls into.


XSAT:RESP
33GF Score
Respiratorius AB XSAT:RESP
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Respiratorius AB Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Respiratorius AB's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Respiratorius AB's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=3.463/134.6100*134.6100
=3.463

Current CPI (Jun. 2026) = 134.6100.

Respiratorius AB Quarterly Data

Book Value per Share CPI Adj_Book
201606 9.636 101.019 12.840
201609 8.860 101.138 11.792
201612 8.024 102.022 10.587
201703 7.228 102.022 9.537
201706 6.437 102.752 8.433
201709 5.694 103.279 7.421
201712 16.885 103.793 21.898
201803 14.346 103.962 18.575
201806 13.437 104.875 17.247
201809 12.742 105.679 16.230
201812 12.037 105.912 15.299
201903 11.148 105.886 14.172
201906 10.393 106.742 13.106
201909 9.624 107.214 12.083
201912 9.129 107.766 11.403
202003 8.036 106.563 10.151
202006 6.985 107.498 8.747
202009 14.994 107.635 18.752
202012 14.303 108.296 17.778
202103 13.198 108.360 16.395
202106 21.955 108.928 27.131
202109 27.168 110.338 33.144
202112 24.477 112.486 29.291
202204 31.665 115.534 36.893
202209 11.557 122.296 12.721
202212 11.745 126.365 12.511
202303 10.948 127.042 11.600
202306 10.345 129.407 10.761
202309 9.906 130.224 10.240
202312 9.067 131.912 9.252
202403 8.465 132.205 8.619
202406 8.502 132.716 8.623
202409 6.311 132.304 6.421
202412 5.902 132.987 5.974
202503 5.509 132.825 5.583
202506 5.155 133.699 5.190
202509 4.085 133.480 4.120
202512 3.873 133.390 3.908
202603 3.654 133.560 3.683
202606 3.463 134.610 3.463

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Respiratorius AB Business Description

Address Scheelevagen 2, Medicon Village, Lund, SWE, 223 81
Respiratorius AB develops pharmaceutical drugs to treat the common diseases namely Cancer, Chronic Obstructive Pulmonary Disease (COPD), and asthma as well as better methods for diagnosing cardiovascular diseases. The company's drug candidates includes RCD405, VAL001, RESP2000, RESP3000, RESP9000, and RESP1000.
33GF Score

Get the complete analysis for XSAT:RESP

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr2.33
Price